Essential myoclonus: response to anticholinergic therapy.
Benztropine mesylate (Cogentin) in total daily dosages of 4 to 9 mg markedly suppressed the involuntary jerking movements in three patients (a brother and sister and a third apparently sporadic case) with essential myoclonus.
D000293:Adolescent; D001590:Benztropine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D009207:Myoclonus / Q000188:drug therapy* / Q000235:genetics; D010276:Parasympatholytics / Q000627:therapeutic use*; D014326:Tropanes / Q000627:therapeutic use*
D010276:Parasympatholytics; D014326:Tropanes; D001590:Benztropine